News & Events

Blue Earth touts addition of Axumin to NCCN guidelines


February 20, 2018 — Blue Earth Diagnostics said that its Axumin (fluciclovine F-18) PET radiopharmaceutical has been added to the latest version of the National Comprehensive Cancer Network (NCCN) guidelines for prostate cancer.

In version 1.2018 of the guidelines, the NCCN noted that either F-18 fluciclovine PET/CT or PET/MRI should be considered in the clinical workup of patients with recurrence or progression of their prostate cancer, according to Blue Earth. Axumin is indicated for use in PET imaging to identify suspected sites of prostate cancer recurrence in men who have elevated blood levels of prostate-specific antigen (PSA) after prior treatment.

Welcome Dr. Fernandez

Radiology and Imaging Specialists Announce Addition to Medical Staff

Radiology and Imaging Specialists is proud to announce an addition to their medical staff. Alexander J. Fernandez has joined the practice as board-certified radiologist. He received his Bachelor of Arts in Philosophy and Chemistry from New York University, NY, NY and received his medical degree from University of Michigan Medical School in Ann Arbor, MI. Dr. Fernandez holds a Masters Degree in Business Administration from Duke University in Durham, NC. He completed his internship at the University of Michigan Health System in Ann Arbor, MI and was Nuclear Medicine Chief Resident at Yale New Haven Hospital in New Haven, CT. He completed his Fellowship in MRI at St. Francis Medical Center in Hartford, CT.